CD274 and neuroblastoma: Hence, the current study is focused on studying if BTK is expressed in MDSCs isolated from NB tumors and if ibrutinib can reduce MDSC-mediated immunosuppression to enhance the efficacy of anti-PDL1 therapy in NB.